Literature DB >> 32886434

Long-term risk of dementia following hospitalization due to physical diseases: A multicohort study.

Pyry N Sipilä1,2, Joni V Lindbohm1,3, Archana Singh-Manoux3,4, Martin J Shipley3, Tuomo Kiiskinen5, Aki S Havulinna5,6, Jussi Vahtera7,8, Solja T Nyberg1,9, Jaana Pentti1,7,9, Mika Kivimäki1,2,3.   

Abstract

INTRODUCTION: Conventional risk factors targeted by prevention (e.g., low education, smoking, and obesity) are associated with a 1.2- to 2-fold increased risk of dementia. It is unclear whether having a physical disease is an equally important risk factor for dementia.
METHODS: In this exploratory multicohort study of 283,414 community-dwelling participants, we examined 22 common hospital-treated physical diseases as risk factors for dementia.
RESULTS: During a median follow-up of 19 years, a total of 3416 participants developed dementia. Those who had erysipelas (hazard ratio = 1.82; 95% confidence interval = 1.53 to 2.17), hypothyroidism (1.94; 1.59 to 2.38), myocardial infarction (1.41; 1.20 to 1.64), ischemic heart disease (1.32; 1.18 to 1.49), cerebral infarction (2.44; 2.14 to 2.77), duodenal ulcers (1.88; 1.42 to 2.49), gastritis and duodenitis (1.82; 1.46 to 2.27), or osteoporosis (2.38; 1.75 to 3.23) were at a significantly increased risk of dementia. These associations were not explained by conventional risk factors or reverse causation. DISCUSSION: In addition to conventional risk factors, several physical diseases may increase the long-term risk of dementia.
© 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

Entities:  

Keywords:  cohort studies; dementia; disease; hospitalization; risk factors

Mesh:

Year:  2020        PMID: 32886434      PMCID: PMC7754402          DOI: 10.1002/alz.12167

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  48 in total

1.  Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.

Authors:  Linda E Lévesque; James A Hanley; Abbas Kezouh; Samy Suissa
Journal:  BMJ       Date:  2010-03-12

2.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

Review 3.  The projected effect of risk factor reduction on Alzheimer's disease prevalence.

Authors:  Deborah E Barnes; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2011-07-19       Impact factor: 44.182

4.  Bone mineral density and the risk of Alzheimer disease.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Yuqing Zhang; David Felson; Marian T Hannan; Rhoda Au; Philip A Wolf; Douglas P Kiel
Journal:  Arch Neurol       Date:  2005-01

Review 5.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

Review 6.  Post-infectious autoimmune disorders: Sydenham's chorea, PANDAS and beyond.

Authors:  Kyle A Williams; Susan E Swedo
Journal:  Brain Res       Date:  2014-10-07       Impact factor: 3.252

7.  Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study.

Authors:  Michaël Schwarzinger; Bruce G Pollock; Omer S M Hasan; Carole Dufouil; Jürgen Rehm
Journal:  Lancet Public Health       Date:  2018-02-21

Review 8.  Chronic gastritis.

Authors:  Pentti Sipponen; Heidi-Ingrid Maaroos
Journal:  Scand J Gastroenterol       Date:  2015-04-22       Impact factor: 2.423

9.  Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis.

Authors:  Mika Kivimäki; Archana Singh-Manoux; Jaana Pentti; Séverine Sabia; Solja T Nyberg; Lars Alfredsson; Marcel Goldberg; Anders Knutsson; Markku Koskenvuo; Aki Koskinen; Anne Kouvonen; Maria Nordin; Tuula Oksanen; Timo Strandberg; Sakari B Suominen; Töres Theorell; Jussi Vahtera; Ari Väänänen; Marianna Virtanen; Peter Westerholm; Hugo Westerlund; Marie Zins; Sudha Seshadri; G David Batty; Pyry N Sipilä; Martin J Shipley; Joni V Lindbohm; Jane E Ferrie; Markus Jokela
Journal:  BMJ       Date:  2019-04-17

10.  A claims data-based comparison of comorbidity in individuals with and without dementia.

Authors:  Kathrin Bauer; Larissa Schwarzkopf; Elmar Graessel; Rolf Holle
Journal:  BMC Geriatr       Date:  2014-01-28       Impact factor: 3.921

View more
  4 in total

1.  Association of a wide range of chronic diseases and apolipoprotein E4 genotype with subsequent risk of dementia in community-dwelling adults: A retrospective cohort study.

Authors:  Xianwen Shang; Zhuoting Zhu; Xueli Zhang; Yu Huang; Xiayin Zhang; Jiahao Liu; Wei Wang; Shulin Tang; Honghua Yu; Zongyuan Ge; Xiaohong Yang; Mingguang He
Journal:  EClinicalMedicine       Date:  2022-03-13

2.  Immune-mediated diseases are associated with a higher incidence of dementia: a prospective cohort study of 375,894 individuals.

Authors:  Ya-Ru Zhang; Liu Yang; Hui-Fu Wang; Bang-Sheng Wu; Shu-Yi Huang; Wei Cheng; Jian-Feng Feng; Jin-Tai Yu
Journal:  Alzheimers Res Ther       Date:  2022-09-13       Impact factor: 8.823

3.  Long-term risk of dementia following hospitalization due to physical diseases: A multicohort study.

Authors:  Pyry N Sipilä; Joni V Lindbohm; Archana Singh-Manoux; Martin J Shipley; Tuomo Kiiskinen; Aki S Havulinna; Jussi Vahtera; Solja T Nyberg; Jaana Pentti; Mika Kivimäki
Journal:  Alzheimers Dement       Date:  2020-09-04       Impact factor: 16.655

4.  Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.

Authors:  Joni V Lindbohm; Nina Mars; Keenan A Walker; Archana Singh-Manoux; Gill Livingston; Eric J Brunner; Pyry N Sipilä; Kalle Saksela; Jane E Ferrie; Ruth C Lovering; Stephen A Williams; Aroon D Hingorani; Rebecca F Gottesman; Henrik Zetterberg; Mika Kivimäki
Journal:  Alzheimers Dement       Date:  2021-08-02       Impact factor: 16.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.